Urges protection of Medicare or veterans' benefits for medical device treatments for male incontinence and impotence that result from treatment for prostate cancer, diabetes, cardiovascular disease, Parkinson's disease, or multiple sclerosis. Expresses that coverage decisions should be based on data and made after careful review by medical experts.